Talk:25CN-NBOH

Requested move

 * The following discussion is an archived discussion of the proposal. Please do not modify it. Subsequent comments should be made in a new section on the talk page. No further edits should be made to this section. 

The result of the proposal was moved. --BDD (talk) 19:06, 31 January 2014 (UTC)

– There are several pages on Wikipedia about the N-benzylphenethylamine class of psychedelics. These are ususally named in three different ways.
 * NBOH-2C-CN → 25CN-NBOH
 * NBOMe-2C-D → 25D-NBOMe
 * 2C-TFM-NBOMe → 25TFM-NBOMe

The 'Braden' nomenclature established in the seminal 2006 paper by Braden et al. (Mol. Pharmacol. 2006, 70(6), 1956-1964, doi:10.1124/mol.106.028720) uses the format 25X-NBYYY, where '25' denotes that the two methoxy groups are in the 2 and 5 position, the 'X' is the 4-sustituent usually a halogen, alkyl or thioalkyl group and is named using the same nomenclature as Alexander Shulgin uses in Pihkal for '2C-X' compounds e.g. C for chlorine, D, for methyl, T2 for thioethyl etc. The N-benzyl part of the molecule is described by the 'NBOMe' which means 2-methoxybenzyl, 'NBF' means 2-fluorobenzyl, 'NBOH' means 2-hydroxybenzyl, 'NBMD' means 2,3-methylenedioxybenzyl etc.

Other naming schemes include a combination of Shulgin and Braden nomenclature e.g '2C-C-NBOMe' and 'NBOMe-2C-C' both of which are non-canonical and contribute to the confusion between simple phenethylamines such as 2C-C and their N-benzyl counterparts i.e. 25C-NBOMe. Not only is it annoying that articles exist using all three naming schemes, the use of the non-canonical terms makes it more difficult for users to distinguish between compounds that may be 100 fold more potent and this confusion has led to overdoses in the past. Therefore, I request that all N-benzylphenethylamine articles be moved to Braden nomenclature pages. Pjw154 (talk) 11:42, 17 January 2014 (UTC)
 * The above discussion is preserved as an archive of the proposal. Please do not modify it. Subsequent comments should be made in a new section on this talk page. No further edits should be made to this section.